Plan Ii Thesis Symposium

Plan Ii Thesis Symposium-19
He belongs to the editorial advisory board of several medicinal chemistry journals and serves as the Editor-in-Chief of the Medicinal Chemistry Section of the MDPI journal Molecules. Diego Muñoz-Torrero is Associate Professor of Organic and Medicinal Chemistry at the Faculty of Pharmacy and Food Sciences, University of Barcelona (UB).He belongs to the editorial advisory board of several medicinal chemistry journals and serves as the Editor-in-Chief of the Medicinal Chemistry Section of the MDPI journal Molecules. Javier Luque is a Professor from the University of Barcelona (UB) and member of the Institute of Biomedicine (IBUB) and Institute of Theoretical and Computational Chemistry (IQTC).He is a member of the Computational Biology and Drug Design research group.

He belongs to the editorial advisory board of several medicinal chemistry journals and serves as the Editor-in-Chief of the Medicinal Chemistry Section of the MDPI journal Molecules. Diego Muñoz-Torrero is Associate Professor of Organic and Medicinal Chemistry at the Faculty of Pharmacy and Food Sciences, University of Barcelona (UB).He belongs to the editorial advisory board of several medicinal chemistry journals and serves as the Editor-in-Chief of the Medicinal Chemistry Section of the MDPI journal Molecules. Javier Luque is a Professor from the University of Barcelona (UB) and member of the Institute of Biomedicine (IBUB) and Institute of Theoretical and Computational Chemistry (IQTC).

Since 1998 she is full professor of Pharmaceutical Chemistry at Bonn University.

She is a co-founder of the Pharma-Center Bonn, and has ca.

She has published 52 papers in peer-reviewed international journals (J. Her team is part of the drug discovery lab affiliated to the University of Lille, the Institut Pasteur de Lille and INSERM. She did her Ph D under the supervision of Pr Tartar (1996-1999) on combinatorial chemistry.

She has been awarded the joined French Society of Medicinal Chemistry (SCT) & Servier Prize (2009. She has been nominated member of the Institut Universitaire de France in 2015.

The MMCS2019 will be organized into a number of thematic sessions on medicinal chemistry of particularly challenging diseases, novel and revisited drug discovery approaches, and medicinal chemistry stories about recently implemented projects in any area not covered in the other sessions, from target and hit identification to hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.

Two prominent and inspiring keynote speakers per session will share the program with a number of selected oral communications, especially by young researchers. Diego Muñoz-Torrero Editor-in-Chief of the Medicinal Chemistry Section of Prof.

Bio Alessio Ciulli holds the Personal Chair of Chemical and Structural Biology at the University of Dundee.

Kinetic Target-Guided Synthesis as a Tool for Drug-Discovery: Successes, Challenges and Applications to Metalloproteases Pr. Deprez-Poulain, Ph D, Pharm D, is Full Professor of Medicinal Chemistry and Drug Discovery at the School of Pharmacy in Lille.

and follows the very successful one-day meeting,"Molecules Medicinal Chemistry Symposium (MMCS): Emerging Drug Discovery Approaches against Infectious Diseases", held in September 2017 at the School of Pharmacy and Food Sciences of the University of Barcelona, Spain, which turned out to be a very fruitful forum for discussion on the specific topic of anti-infective drug discovery, in an excellent atmosphere created by the more than 70 attendees from 20 countries.

Encouraged by the great success of the initial small-format monographic MMCS2017, the three-day MMCS2019 will grow naturally by addressing a larger audience and essentially all topics of medicinal chemistry.

SHOW COMMENTS

Comments Plan Ii Thesis Symposium

The Latest from homologation.ru ©